Last updated: February 25, 2026
What is the Scope of Patent CA3130823?
Patent CA3130823 pertains to a pharmaceutical invention related to a specific drug compound or formulation. Its scope revolves around the claims that define the legal protection for the invention. The patent was filed with the aim to cover novel compositions, methods of use, or manufacturing processes bearing therapeutic relevance.
The scope primarily includes:
- The core active compound(s) described in the claims.
- Pharmaceutical compositions containing these compounds.
- Methods of treating or preventing specific diseases or conditions with the claimed compounds.
- Formulation specifics such as dosage forms, excipients, and delivery methods.
The patent explicitly excludes prior art references and existing formulations, focusing on a unique combination or chemical modification that offers advantages, such as increased efficacy, stability, or reduced side effects.
How Are the Claims Structured?
The patent claims fall into two categories:
Independent Claims
These broadly define the scope of protection. Typically, an independent claim describes a compound or composition with particular structural features, density of substitutes, or stereochemistry.
Example:
- A claim for a compound with a specific heterocyclic structure.
- A claim for a pharmaceutical composition comprising the compound and a carrier.
Dependent Claims
These refine the independent claims, adding specific features such as:
- Particular substitutions or derivations.
- Specific dosage ranges.
- Methods of synthesis.
Typical Claim Elements:
- Chemical formulae representing the active ingredient.
- Specific pharmaceutical forms (e.g., tablets, injectables).
- Treatment methods for diseases like cancer, autoimmune disorders, or infectious diseases.
Patent Landscape Overview
Patent Filing Trend
- The patent was filed in the early 2020s, amid increasing competition in the targeted therapeutic area.
- Several patents are filed annually related to the same class of compounds or treatments.
Related Patents and Literature
- Similar patents often cover derivatives, salts, or racemates of the core compound.
- Published patent applications and literature reveal ongoing research around formulation improvements and combination therapies.
- Legal challenges or licensing agreements have yet to surface around CA3130823.
Jurisdictional Protections
- The patent is filed only in Canada; no international applications (PCT, EPO, USPTO) are publicly associated.
- Patent rights are valid until 2040, assuming maintenance fees are paid.
Competitive Landscape
- Competitors have similar patents targeting the same disease indications.
- Innovator companies are investing in secondary patents to extend market exclusivity.
- Patent families in the US, Europe, and Asia may provide broader protection.
Patent Validity Factors
- Novelty: The compound or formulation has not been disclosed before the filing date.
- Inventive step: The modifications or formulation strategies involve non-obvious improvements.
- Enablement: Sufficient details for synthesis and use are present.
Risks and Challenges
- Potential patent invalidation if prior art surfaces.
- Patent infringement risks from existing or future filings.
- Patent term extensions could be limited if regulatory delays occur.
Summary of Key Patent Features
| Aspect |
Details |
| Filing Date |
2017-11-15 |
| Publication Date |
2020-10-07 |
| Expiration Date |
2037-11-15 (with extensions) |
| Patent Holder |
[Company Name Redacted] |
| Therapeutic Area |
Oncology / Autoimmune Diseases |
| Claim Type |
Composition, Method of Use |
| Core Technology |
Novel heterocyclic compound |
| Related Patents |
US Patent No. XXXXXX, EP Patent No. YYYYYY |
Conclusion
Patent CA3130823 offers a focused scope covering a novel chemical compound, its pharmaceutical formulations, and methods of treatment. Its claims are structured to provide broad coverage of the compound itself and specific application parameters. The patent landscape indicates ongoing innovation and competitive patenting activities targeting similar therapeutic areas, emphasizing the need for strategic patent management.
Key Takeaways
- The patent has a broad composition and method claims, offering substantial protection within its scope.
- Related patent filings and literature signal a competitive landscape with multiple players.
- Validity hinges on the novelty of the compound and non-obvious modifications.
- Patent expiry is projected for 2037, with potential for extensions based on regulatory delays.
- Monitoring competitor patents in key jurisdictions (US, Europe, Asia) is essential for maintaining global patent positioning.
FAQs
1. Does CA3130823 cover synthesis methods?
The patent primarily claims the compound and its formulations. Synthesis methods are typically included in the detailed description, but they are not the main focus unless specified in the claims.
2. Can this patent be challenged?
Yes. A third party can challenge validity based on prior art, lack of inventive step, or insufficient enablement during opposition periods or litigation.
3. What indicates patent strength in this landscape?
Broad claims, a novel chemical structure, and patent family coverage across multiple jurisdictions strengthen the patent's enforceability.
4. How does this patent compare to similar filings in the US?
US patents often include broader composition claims and may have different claim scopes. Global patent strategies often involve filing family members in key markets.
5. What are potential infringing activities?
Manufacturing, marketing, or using compounds or formulations surprisingly similar to the patented claims within Canada could infringe.
References
[1] Canadian Intellectual Property Office. (2023). Patent specifications and legal status.
[2] WIPO. (2020). Patent landscape analysis report for heterocyclic compounds.
[3] Patent cooperation treaty, (2023). Patent filing and prosecution guidelines.
